Company Overview and News

 
Explaurum attracts broker Speculative Buy rating as Tampia takes shape

2017-11-24 proactiveinvestors.com.au
Explaurum Ltd (ASX:EXU) has received a Speculative Buy from broker Hartleys, which has set a 12-month price target of $0.20.

 
Explaurum set to drill around gold resource at Tampia

2017-11-21 proactiveinvestors.com.au
Explaurum Ltd (ASX:EXU) is about to drill around the resource area of its Tampia Gold Project in Western Australia to test for extensions to mineralisation.

 
Explaurum scoping study supports high margin gold mine

2017-11-04 proactiveinvestors.com.au
Explaurum (ASX:EXU) has received the results of its scoping study based on an open-pit gold mine within the Tampia Gold Project located 250 kilometres east of Perth, Western Australia.

 
Explaurum drills out visible gold indicating growth potential

2017-10-31 proactiveinvestors.com.au
Explaurum (ASX:EXU) has received assay results from five diamond holes drilled for metallurgical test work purposes at the Tampia Gold Project located in Western Australia.

 
Explaurum commences intensive exploration phase

2017-10-20 proactiveinvestors.com.au
Explaurum (ASX:EXU) has commenced regional exploration aimed at adding gold ounces to its emerging Tampia Gold Project located in Western Australia.

 
Explaurum reveals a significant upgrade for Tampia gold resource

2017-09-13 proactiveinvestors.com.au
Explaurum Ltd (ASX:EXU) has delivered a significant resource upgrade for its Tampia Gold Project in Western Australia to 11.3 million tonnes at 1.91 g/t gold for 695,500 ounces of gold.

 
Explaurum drills bonanza grade gold at Tampia

2017-08-07 proactiveinvestors.com.au
Explaurum (ASX:EXU) has assayed up to 716 g/t gold in its latest set of results from drilling at the Tampia Gold Project located 300 kilometres east of Perth in Western Australia.

 
Explaurum to boost cash position ahead of gold resource upgrade

2017-07-26 proactiveinvestors.com.au
Explaurum Ltd (ASX:EXU) remains focused on the Tampia Gold Project in Western Australia, which hosts a historical Inferred resource 4.7 million tonnes at 2.0g/t gold for 310,000 ounces.

 
Explaurum Ltd continues to assay high-grade gold

2017-07-05 proactiveinvestors.com.au
Explaurum Ltd (ASX:EXU) has received a new batch of results from the ongoing resource drilling program at the Tampia Gold Project, located 300 kilometres from Perth in Western Australia.

 
Explaurum new drill results confirm high grade gold zones

2017-06-13 proactiveinvestors.com.au
Explaurum (ASX:EXU) has received its third batch of results from the resource drilling program metres at the Tampia Gold Project, located 300 kilometres east of Perth in Western Australia.

 
Explaurum generates three new gold drill targets

2017-05-17 proactiveinvestors.com.au
Explaurum (ASX:EXU) has completed a 400 square kilometre regional airborne gravity and magnetic survey at its flagship Tampia Gold Project located in Western Australia.

 
Explaurum delivers better than expected gold recoveries

2017-05-08 proactiveinvestors.com.au
Explaurum (ASX:EXU) has achieved high gold recovery results from comprehensive metallurgical test work undertaken at the Tampia Gold Project in Western Australia.

 
Explaurum expands resource area with high grade gold hits

2017-05-02 proactiveinvestors.com.au
Explaurum (ASX:EXU) has drilled out up to 185 g/t gold in its latest batch of assay results from its reverse circulation drilling program at the Tampia Gold Project in Western Australia.

 
Explaurum initial assays suggest gold resource expansion

2017-04-12 proactiveinvestors.com.au
Explaurum (ASX:EXU) has received its first batch of assays from resource drilling at its flagship Tampia Gold Project located 300 kilometres east of Perth in Western Australia.

 
Explaurum substantial shareholder increases stake

2017-03-22 proactiveinvestors.com.au
Explaurum (ASX:EXU) substantial shareholder, West Trade Enterprises Pty Ltd, has increased its stake in the company to 7.35% from 6.77%.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...